3651 results for «396»
3651 results
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
Renal denervation in the real-world: performance in high risk subgroups
05 Oct 2021 – From AICT-AsiaPCR 2021
After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...
Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients
06 Oct 2021 – From AICT-AsiaPCR 2021
In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...
Cases and complications: coronary perforation
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to learn more about various complications of coronary perforation and discover how to face them, thanks to a selection of challenging cases.
IVUS-guided left main / left main bifurcation with Megatron
09 Oct 2021 – From AICT-AsiaPCR 2021
How to optimise outcome when treating complex lesions like left main? Watch this session to find out more about the new tools that can help! You will also learn how to overcome the complexities of left main / left main bifurcations with new technologies, and you will be proposed a...
We CARE in 2023: Measuring the pandemic’s impact and developing tools to build resilience for the future
18 May 2023
The COVID-19 pandemic caused huge disruption to healthcare services and dramatically reduced hospital admissions for MI.1 In response, the We CARE initiative was created from a collaboration between PCR and Stent – Save a Life! to rebuild patient confidence in pursuing timely medical treatment and to help...
We CARE about hearts - EuroPCR 2022
19 May 2022
The aims of We CARE are to rebuild patient confidence and help stakeholders provide effective and timely cardiac care through knowledge, education and training.
Author
We CARE: a joint initiative by PCR and Stent – Save a Life!
07 May 2021
Paris, France. Since the start of the COVID-19 pandemic, patients have been consistently deprived of timely cardiovascular treatment. This is due in part to measures taken in response to the sanitary crisis, but it is also due to patients' own unwillingness to seek medical help, even...
RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration
04 Nov 2021
Panos Xaplanteris review the RADIANCE-HTN Study, presented by Ajay Kirtane, an international randomized, sham-controlled clinical trial evaluating the safety and efficacy of renal denervation (RDN) in a population of treatment-resistant hypertensive patients.
Author
TAILORED-CHIP: Tailored antiplatelet therapy for complex high-risk PCI
29 Aug 2025
Nicola Ryan provides her take on the results of TAILORED-CHIP presented by Duk-Woo Park at the ESC Congress 2025 in Madrid.
Author
Insights from the Corevalve US Pivotal and SURTAVI trials
05 Apr 2022
Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.
Author
Author
